SCHEMBL2717035

SCHEMBL2717035

CC(C)(C)OC(=O)NCCc1nc2c(F)cccc2c(C(=O)O)c1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.41
SCN9A Q15858 1/20 0.41
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
CKS1B P61024 1/20 0.40
SKP1 P63208 1/20 0.40
SKP2 Q13309 1/20 0.40
IDO1 P14902 2/20 0.40
BCHE P06276 1/20 0.39
TACR3 P29371 2/20 0.38
TACR2 P21452 1/20 0.38
ACACB O00763 1/20 0.37
GBA1 P04062 1/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2717730 0.92 ADORA2A (0.41) NQO2SCN9AADORA2AADORA1CKS1B
SCHEMBL2719668 0.86 LMNA (0.47) NQO2CKS1BSKP1SKP2IDO1
SCHEMBL2719206 0.83 DHODH (0.46) NQO2CKS1BSKP1SKP2
SCHEMBL1694879 0.78 NQO2 (0.47) NQO2SCN9AADORA2ACKS1BSKP1
SCHEMBL2717033 0.78 CTSK (0.39) TACR3TACR2CTSSCTSK
SCHEMBL2717152 0.77 ACACB (0.45) NQO2CKS1BSKP1SKP2IDO1
SCHEMBL2719177 0.76 DHODH (0.50) NQO2CKS1BSKP1SKP2IDO1
SCHEMBL2716769 0.75 PIK3CD (0.43) NQO2CKS1BSKP1SKP2IDO1
SCHEMBL2720609 0.74 PIK3CD (0.47) NQO2CKS1BSKP1SKP2ACACB
SCHEMBL1694905 0.74 NQO2 (0.47) NQO2SCN9AIDO1BCHEACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445900-A2 POLYCYCLIC DERIVATIVES OF PYRIDINE AND THEIR USE IN THE TREATMENT OF (INTER ALIA) RHEUMATOID ARTHRITIS AND SIMILAR DISEASES Amgen, Inc (US) 2012-05-02 EP disclosed
WO-2010151740-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2010-12-29 WO disclosed